Clinical Operations

Clinical trial recruitment SLA from intake to screening

A practical SLA guide for clinical trial recruitment handoffs from intake through prescreen review, records readiness, scheduling, and stale-lead review.

A recruitment SLA should make the next action visible before patient interest goes stale. It needs timing targets, ownership, blocker categories, and escalation rules that fit the study workflow.

In this guide

Key points

  • Define response, prescreen review, records request, scheduling, and stale-lead review targets separately.
  • Track the reason a patient is waiting instead of only tracking age in queue.
  • Escalate blockers that require sponsor, study-team, or site-lead decisions.

Response time is only the first SLA

Fast first follow-up matters, but it is not the whole workflow. A patient can be contacted quickly and still stall because prescreen review, records collection, scheduling, or criteria clarification has no clear owner.

A practical SLA breaks the workflow into stages so the team can see which part is waiting.

Set stage-specific targets

Common stages include new inquiry review, first outreach, prescreen completion, coordinator review, records request, records received, ready to schedule, scheduled screening visit, and stale-lead review.

Each stage should have an owner, a reasonable timing target, and a close reason for patients who should not continue. The point is to prevent silent aging, not to force every patient through the same path.

Track blocker reason alongside age

Age in queue tells the team that something is waiting. Blocker reason tells the team what to do about it. No response, missing records, pending review, scheduling conflict, source mismatch, and criteria question require different actions.

That distinction is what makes an SLA useful in a real recruiting operation.

Define escalation without creating noise

Escalation should be reserved for blockers that need a decision: repeated records friction, unclear criteria language, visit capacity issues, low source quality, or a coordinator queue that is consistently over capacity.

A good escalation note names the blocker, the affected study or site, the owner, and the decision needed by the next reporting cycle.

Review the SLA weekly

The SLA should be reviewed with the actual recruiting queue. Which patients moved, which stalled, what reasons repeated, and what changed after last week's actions?

That review keeps the SLA grounded in patient momentum rather than turning it into a static policy document.

Sources and editorial notes

Published .

This guide explains recruitment work and questions to discuss with your team.

This information is educational. Your study team makes medical, eligibility, and enrollment decisions.

See TrialsNest in action

Bring this workflow into one place.

Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.

Site clinical operations

Coordinator Today

Your inquiries, priorities, and upcoming visits.

Inquiries assigned
14
3 pending review
Visits today
6
4 in person · 2 virtual
Action priorities
4
Needs attention
Active studies
3
Study A · B · C
Daily priorities

Priority tasks

  • Review screening intakeInquiry 001 · Study A
    Completed
  • Verify specimen preparationStudy A · Due 10:00 AM
    Completed
  • Confirm visit windowInquiry 003 · Follow-up
    Pending
Today’s schedule

Upcoming visits

  1. In personInquiry 001

    Study A · Baseline visit

    View visit details →
  2. TelehealthInquiry 003

    Study A · Prescreen

    Review appointment →
  3. In personInquiry 004

    Study B · Week 4

    View visit details →

Keep reading